IMU Biosciences - About the company
IMU Biosciences is a series A company based in London (United Kingdom), founded in 2019 by Adam Laing and Tom Hayday. It operates as a Provider of immune discovery platform for precision medicines. IMU Biosciences has raised $53M in funding from Molten Ventures and IQ Capital. The company has 115 active competitors, including 34 funded and 4 that have exited. Its top competitors include companies like Cellworks, Geneyx and ICarbonX.
Company Details
Provider of immune discovery platform for precision medicines. The company uses immune profiling with a proprietary machine learning and Artificial intelligence platform to revolutionize immune-powered precision medicine.
- Website
- www.imubiosciences.com/
- Email ID
- *****@imubiosciences.com
Key Metrics
Founded Year
2019
Location
London, United Kingdom
Stage
Series A
Total Funding
$53M in 2 rounds
Latest Funding Round
Investors
Ranked
3rd among 115 active competitors
Employee Count
85 as on Sep 30, 2026
Sign up to download IMU Biosciences' company profile
IMU Biosciences's funding and investors
IMU Biosciences has raised a total funding of $53M over 2 rounds. Its first funding round was on Jan 24, 2024. Its latest funding round was a Series A round on Jun 02, 2026 for $*****. 4 investors participated in its latest round. IMU Biosciences has 6 institutional investors.
Here is the list of recent funding rounds of IMU Biosciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 02, 2026 | 8076069 | Series A | 5517705 | 6207172 | 8711621 | 4817032 |
Jan 24, 2024 | 4818758 | Series A | 7887275 | 9366375 |
View details of IMU Biosciences's funding rounds and investors
IMU Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of IMU Biosciences are Adam Laing and Tom Hayday. Adam Laing is the CEO of IMU Biosciences.
Here are the details of IMU Biosciences' key team members:
- Adam Laing: Co-Founder & CEO of IMU Biosciences. Contact Info: 1 email address
- Tom Hayday: Co-Founder of IMU Biosciences. Contact Info: 1 email address
View details of IMU Biosciences's Founder profiles and Board Members
IMU Biosciences' employee count trend
IMU Biosciences has 85 employees as of Sep 26. Here is IMU Biosciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
IMU Biosciences's Competitors and alternates
Top competitors of IMU Biosciences include Cellworks, Geneyx and ICarbonX. Here is the list of Top 10 competitors of IMU Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 67/100 | |
2nd | Provider of a clinical genetics data management platform for hospitals and genetic labs | $10M | 57/100 | ||
3rd | IMU Biosciences 2019, London (United Kingdom), Series A | Provider of immune discovery platform for precision medicines | $53M | 56/100 | |
4th | Provider of bioinformatic platforms for health management and drug development | $366M | 55/100 | ||
5th | Biostate 2023, Houston (United States), Series A | Developer of generative AI based RNAstate research platform to predict future omics states | $16M | 53/100 | |
6th | Provider of an AI-enabled immunotherapy based tumor diagnostic platform | $38.2M | 52/100 | ||
7th | Life Bit 2017, London (United Kingdom), Series B | AI and SaaS-based genomics analysis software for drug development | $70.9M | 51/100 | |
8th | Watershed 2019, Sacramento (United States), Series A | Provider of software solution for biological data analysis, discovery, and collaboration | $19.7M | 48/100 | |
9th | Liquid Biosciences 2017, Aliso Viejo (United States), Series C | Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes | $40.1M | - | 48/100 |
10th | ROSALIND 2013, San Diego (United States), Seed | Cloud-based collaborative bioinformatics platform for researchers | $70K | 45/100 |
Looking for more details on IMU Biosciences's competitors? Click here to see the top ones
IMU Biosciences's Investments and acquisitions
IMU Biosciences has made no investments or acquisitions yet.
Reports related to IMU Biosciences
Here is the latest report on IMU Biosciences's sector:
News related to IMU Biosciences
Media has covered IMU Biosciences for a total of 7 events in the last 1 year, 2 of them have been about partnerships and 2 about people movement.
•
IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development ProgrammesBusiness Wire•Sep 09, 2026•Transplant Genomics, IMU Biosciences
•
IMU Biosciences Partners with Waters Corporation to Advance AI Immune Mapping Platform for Precision MedicineCNW•Jun 24, 2026•IMU Biosciences, Waters Corporation, Societe Generale
•
IMU Biosciences Secures £40m Funding to Advance Disease DiagnosisUKTN•Jun 02, 2026•Molten Ventures, IMU Biosciences, Meltwind Advisory, British Business Bank and 1 other
•
IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive DirectorGlobeNewswire•Nov 20, 2025•IMU Biosciences
•
IMU Biosciences Announces Formation of Scientific Advisory BoardGlobeNewswire•Nov 13, 2025•IMU Biosciences
•
Coulter Partners Recruits CEO and Chief Business Officer for IMU BiosciencesHunt Scanlon•Dec 05, 2024•Coulter Partners, IMU Biosciences, Abcam
•
Coulter Partners Strengthens Leadership at IMU Biosciences with Placements of Chief Executive Officer and Chief Business OfficerHunt Scanlon•Nov 12, 2024•Coulter Partners, IMU Biosciences
•
IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapiesGlobeNewswire•Oct 07, 2024•IMU Biosciences
•
IMU Biosciences expands leadership team with appointment of industry experts Dr. John Baker as Chief Executive Officer and Dr. Jason Brown as Chief Business OfficerGlobeNewswire•Sep 17, 2024•IMU Biosciences
•
£11.5m and new chair for MedTech IMU BiosciencesBusinessCloud•Jan 24, 2024•IMU Biosciences, Molten Ventures, Life Extension Ventures, Morressier and 4 others
Are you a Founder ?
FAQs about IMU Biosciences
Explore our recently published companies
- AMPIN Energy Transition - India based, 2023 founded, Unfunded company
- ZSU Webdesign - Hungary based, Unfunded company
- Zuka - United Arab Emirates based, Unfunded company
- Zogglar - Brazil based, 2006 founded, Unfunded company
- Zimmerei Menz - Wenzlow based, Unfunded company
- Zenovation Group - Unfunded company
